121 related articles for article (PubMed ID: 1463806)
1. Brain amyloid in Alzheimer's disease--a new experimental model.
Pavlin R
Neurol Croat; 1992; 41(4):227-34. PubMed ID: 1463806
[TBL] [Abstract][Full Text] [Related]
2. The amyloid peptide and its precursor in Alzheimer's disease.
Octave JN
Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
[TBL] [Abstract][Full Text] [Related]
3. Imaging Alzheimer's amyloid.
Selkoe DJ
Nat Biotechnol; 2000 Aug; 18(8):823-4. PubMed ID: 10932146
[No Abstract] [Full Text] [Related]
4. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
Klausner AP; Sharma S; Fletcher S; Neff P; Yang SK; Son H; Tuttle JB; Steers WD
J Urol; 2008 Mar; 179(3):1173-7. PubMed ID: 18206173
[TBL] [Abstract][Full Text] [Related]
5. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer's disease and amyloid beta-protein].
Ikeda S
No To Shinkei; 1989 Nov; 41(11):1051-64. PubMed ID: 2515890
[No Abstract] [Full Text] [Related]
7. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
8. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease.
Joachim CL; Mori H; Selkoe DJ
Nature; 1989 Sep; 341(6239):226-30. PubMed ID: 2528696
[TBL] [Abstract][Full Text] [Related]
9. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
10. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease.
Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM
FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995
[TBL] [Abstract][Full Text] [Related]
11. [Brain pathology in Alzheimer's disease. Progress in the immunohistochemistry study of amyloid senile plaques].
Ishii T
Nihon Rinsho; 1988 Jul; 46(7):1464-70. PubMed ID: 3065523
[No Abstract] [Full Text] [Related]
12. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
[TBL] [Abstract][Full Text] [Related]
13. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
[TBL] [Abstract][Full Text] [Related]
15. Amyloid imaging in Alzheimer's disease.
Nordberg A
Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
[TBL] [Abstract][Full Text] [Related]
16. A transgenic rat expressing human APP with the Swedish Alzheimer's disease mutation.
Folkesson R; Malkiewicz K; Kloskowska E; Nilsson T; Popova E; Bogdanovic N; Ganten U; Ganten D; Bader M; Winblad B; Benedikz E
Biochem Biophys Res Commun; 2007 Jul; 358(3):777-82. PubMed ID: 17506994
[TBL] [Abstract][Full Text] [Related]
17. Image analysis microspectroscopy of senile plaque capillary amyloid in Alzheimer's disease. A preliminary study.
Pappolla MA
Arch Pathol Lab Med; 1989 Aug; 113(8):866-71. PubMed ID: 2757486
[TBL] [Abstract][Full Text] [Related]
18. Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques.
Steinhoff T; Moritz E; Wollmer MA; Mohajeri MH; Kins S; Nitsch RM
Neurobiol Dis; 2001 Aug; 8(4):647-54. PubMed ID: 11493029
[TBL] [Abstract][Full Text] [Related]
19. The immune system, amyloid-beta peptide, and Alzheimer's disease.
Weksler ME; Gouras G; Relkin NR; Szabo P
Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
[TBL] [Abstract][Full Text] [Related]
20. Gangliosides determine the amyloid pathology of Alzheimer's disease.
Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
